These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4272473)

  • 1. Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy.
    Davis HL; Ramirez G; Ansfield FJ
    Cancer; 1974 Jan; 33(1):193-7. PubMed ID: 4272473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Digestive tract cancer: planning of chemotherapy].
    Hara Y; Tobita Y
    Nihon Rinsho; 1975 May; 33(5):1825-32. PubMed ID: 1171277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Highlights of the 38th Annual Congress of the American Society of Clinical Oncology ASCO 2002].
    Messmann H; Eberl T; Lutz MP; Graeven U
    Z Gastroenterol; 2002 Dec; 40(12):XII-XIX. PubMed ID: 12564417
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radiotherapy and combination radiochemotherapy in the treatment of primary cancers of the liver, pancreas and bile ducts].
    Eschwege F; Rougier P
    Acta Gastroenterol Belg; 1986; 49(2):175-81. PubMed ID: 3544636
    [No Abstract]   [Full Text] [Related]  

  • 5. Protracted ambulatory infusion cancer chemotherapy of the liver and biliary system.
    Sullivan RD; Oberfield RA
    Prog Liver Dis; 1970; 3():481-94. PubMed ID: 4908713
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of hepatic metastases by long-term chemotherapeutic infusions.
    Pettavel J; Morgenthaler F
    Aktuelle Probl Chir; 1970; 14():865-81. PubMed ID: 4146449
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.
    Moertel CG; Childs DS; Reitemeier RJ; Colby MY; Holbrook MA
    Lancet; 1969 Oct; 2(7626):865-7. PubMed ID: 4186452
    [No Abstract]   [Full Text] [Related]  

  • 8. Echographic evaluation of abdominal tumor regression during antineoplastic treatment.
    Kobayashi T; Takatani O; Hattori N; Kimura K
    J Clin Ultrasound; 1974 Jun; 2(2):131-41. PubMed ID: 4211944
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy in gastrointestinal cancer.
    Reitemeier RJ; Moertel CG; Hahn RG
    Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
    Van Dyk JJ; Clarkson BD; Duschinsky R; Keller O; La Sala E; Krakoff IH
    Cancer Res; 1967 Nov; 27(11):2129-36. PubMed ID: 4294532
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our experience with 5-fluoro-2-desocyuridine].
    Brulé G; Hane S
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):153-7. PubMed ID: 4232317
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
    Milano MT; Chmura SJ; Garofalo MC; Rash C; Roeske JC; Connell PP; Kwon OH; Jani AB; Heimann R
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):445-53. PubMed ID: 15145161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of radiation therapy in cancer of the extra-hepatic biliary system: an analysis of thirteen patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy.
    Kopelson G; Harisiadis L; Tretter P; Chang CH
    Int J Radiat Oncol Biol Phys; 1977; 2(9-10):883-94. PubMed ID: 73534
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hepatobiliary neoplasm using cytostatics].
    ilievska M; Davcev P; Vanovski B; Trajanovski D; Bidikov V
    God Zb Med Fak Skopje; 1977; 23():873-9. PubMed ID: 615055
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of chemotherapy in gastric cancer.
    Comis RL; Carter SK
    Cancer; 1974 Nov; 34(5):1576-86. PubMed ID: 4279136
    [No Abstract]   [Full Text] [Related]  

  • 16. Time to move to targeted drugs in biliary tract cancer?
    Louvet C; Tournigand C
    Onkologie; 2010; 33(1-2):10-1. PubMed ID: 20164655
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant/neoadjuvant chemoradiation for gastric and pancreatic cancer.
    Lowy AM; Leach SD
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):121-30. PubMed ID: 10550836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.
    De Jager RL; Magill GB; Golbey RB; Krakoff IH
    Cancer Treat Rep; 1976 Sep; 60(9):1373-5. PubMed ID: 1016970
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical management of advanced gastrointestinal cancer.
    Moertel C
    Semin Drug Treat; 1973; 3(1):55-68. PubMed ID: 4351814
    [No Abstract]   [Full Text] [Related]  

  • 20. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
    Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
    Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.